Severe, primary, and incidental COVID-19 in hospitalised children, South Africa: 2020–2023
Journal of Global Health · 2026
DOI: 10.7189/jogh.16.04009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Health, 2026. Verfasst von Ameena Goga und 27 weiteren Autor:innen. Beteiligte Einrichtung: South African Medical Research Council (SAMRC) HIV and other Infectious Diseases Research Unit, Durban, South Africa (SA). Hauptthemen laut MEDLINE: COVID-19, Hospitalization. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Knowledge gaps persist regarding paediatric COVID-19 clinical presentation, treatment and outcomes in high HIV prevalence settings, with low COVID-19 vaccine coverage.
Methods
An ambi-directional cohort study was conducted in 13 South African public sector hospitals. Hospitalised children with SARS-CoV-2 infection or post-infection syndrome were included. Main outcomes measures included severe disease and primary COVID-19 (hospitalisation for SARS-CoV-2 infection).
Results
There were 2363 SARS-CoV-2 positive children included (March 2020 through May 2023); median age 23.6 months (interquartile range (IQR) = 4.3-98.2 months). Excluding missing values, 1618 (68.9%) children had primary COVID-19; 1121 (69.3%) of these had severe primary COVID-19. In the primary COVID-19 group with data, 318 / 1588 (20.0%) received intensive or high care, 121/1285 (9.4%) received a blood transfusion and 48/1616 (3.0%) died. Multivariable analyses demonstrated that severe primary COVID-19 was 32% higher in children aged 29-365 days (adjusted Risk Ratio (aRR) = 1.32 (95% confidence interval (CI) = 1.13-1.55); reference: 0-28 days), 13% higher with one or more comorbidities (aRR = 1.13; CI = 1.05-1.22)), and 14-22% lower during the Beta, Delta and Omicron periods (reference: ancestral period). Amongst all hospitalised children with a positive SARS-CoV-2 test, severe disease was commoner in underweight children (aRR 1.09; CI = 1.02-1.17, P = 0.013)). Severe signs were commoner in children living with HIV (CLHIV), 88/121 (72.7%), vs. HIV uninfected 1320 / 2104 (62.7%), P = 0.026, and in antiretroviral therapy-naïve CLHIV, (37 / 41 (90.2%), vs. CLHIV on therapy 51 / 80 (63.8%), P = 0.002).
Conclusions
In a high HIV prevalence country, approximately 70% of children with a positive SARS-CoV-2 test were hospitalised for COVID-19 treatment; almost 70% of these children were severely ill. Controlling for other factors, disease severity was highest in the hypothesised pre-immunity Ancestral period. HIV infection and delayed ART initiation were associated with severe signs. In such settings, strengthening general child health programmes to reduce underweight and prevent or treat paediatric HIV may reduce the severity of new diseases of pandemic proportion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- South African Medical Research Council (SAMRC) HIV and other Infectious Diseases Research Unit, Durban, South Africa (SA).
- Department of Paediatrics and Child Health, University of Pretoria, Pretoria, SA.
- Research Centre for Maternal, Fetal, Newborn and Child Health Care Strategies, University of Pretoria, Pretoria, SA.
- SAMRC, Maternal and Infant Health Care Strategies Research Unit, Pretoria, SA.
- Sefako Makgatho Health Sciences, University Department of Paediatrics and Child Health, Pretoria, SA.
- Department of Paediatrics and Child Health, Chris Hani Baragwanath Academic Hospital, School of Clinical Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, SA.
Förderung
- Wellcome Trust
Zitieren
APA
Goga, A., Ramraj, T., Cloete, J., Mawela, D., Waggie, Z., Archary, M., Chinniah, K., Jeena, P., Tabane, N. E., Van Zyl, R., Reubenson, G., Strehlau, R., Feucht, U., Reddy, T., Mchunu, N., Cawood, S., Zühlke, L., Webb, K., Zar, H. J., …, & Moore, D. P. (2026). Severe, primary, and incidental COVID-19 in hospitalised children, South Africa: 2020–2023. Journal of Global Health. https://doi.org/10.7189/jogh.16.04009
Vancouver
Goga A, Ramraj T, Cloete J, Mawela D, Waggie Z, Archary M, et al. Severe, primary, and incidental COVID-19 in hospitalised children, South Africa: 2020–2023. Journal of Global Health. 2026. doi:10.7189/jogh.16.04009
BibTeX
@article{Goga2026,
author = {Goga, Ameena and Ramraj, Trisha and Cloete, Jeané and Mawela, Dini and Waggie, Zainab and Archary, Moherndran and Chinniah, Kogielambal and Jeena, Prakash and Tabane, Nomakhuwa E and Van Zyl, Riana and Reubenson, Gary and Strehlau, Renate and Feucht, Ute and Reddy, Tarylee and Mchunu, Nobuhle and Cawood, Shannon and Zühlke, Liesl and Webb, Kate and Zar, Heather J and Donald, Kirsten A and Scott, Christiaan and Morrow, Brenda M and Aldersley, Thomas and du Plessis, Nicolette M and Chetty, Terusha and Velaphi, Sithembiso and Dangor, Ziyaad and Moore, David P},
title = {Severe, primary, and incidental COVID-19 in hospitalised children, South Africa: 2020–2023},
journal = {Journal of Global Health},
year = {2026},
doi = {10.7189/jogh.16.04009}
}
EUVIMED